Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shogo Inamine"'
Autor:
Noritoshi Shirozu, Masahiro Ohgidani, Nobuhiro Hata, Shunya Tanaka, Shogo Inamine, Noriaki Sagata, Tetsuaki Kimura, Ituro Inoue, Koichi Arimura, Akira Nakamizo, Ataru Nishimura, Naoki Maehara, Soh Takagishi, Katsuma Iwaki, Tomohiro Nakao, Keiji Masuda, Yasunari Sakai, Masahiro Mizoguchi, Koji Yoshimoto, Takahiro A. Kato
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Angiogenic factors associated with Moyamoya disease (MMD) are overexpressed in M2 polarized microglia in ischemic stroke, suggesting that microglia may be involved in the pathophysiology of MMD; however, existing approaches are not applicabl
Externí odkaz:
https://doaj.org/article/cf03e8acbc4144bdad49470e7083ea0b
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 1, Pp 120-125 (2023)
Abstract Aim Several studies reported stress‐induced microglial phagocytosis, but the biochemical mechanisms by which stress alters microglial synaptic phagocytosis are not fully uncovered. Local or limited apoptosis without cell death was observed
Externí odkaz:
https://doaj.org/article/8481ee82c70d4aec8b6c45a71b5896c6
Autor:
Noriaki Sagata, Shin‐ichi Kano, Masahiro Ohgidani, Shogo Inamine, Yasunari Sakai, Hiroki Kato, Keiji Masuda, Takeshi Nakahara, Makiko Nakahara‐Kido, Shouichi Ohga, Masutaka Furue, Akira Sawa, Shigenobu Kanba, Takahiro A. Kato
Publikováno v:
Neuropsychopharmacology Reports, Vol 40, Iss 4, Pp 396-400 (2020)
Abstract Aim Neurofibromatosis type 1 (NF1) is a multifaceted disease, and frequently comorbid with neurodevelopmental disorders such as autism spectrum disorder (ASD) and learning disorder. Dysfunction of adenylyl cyclase (AC) is one of the candidat
Externí odkaz:
https://doaj.org/article/ee59a769ea2f4ccfbc0fe75e7c8893c3
Autor:
Shunya Tanaka, Masahiro Ohgidani, Nobuhiro Hata, Shogo Inamine, Noriaki Sagata, Noritoshi Shirouzu, Nobutaka Mukae, Satoshi O. Suzuki, Hideomi Hamasaki, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Kosuke Takigawa, Yusuke Funakoshi, Toru Iwaki, Masako Hosoi, Koji Iihara, Masahiro Mizoguchi, Takahiro A. Kato
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Targeting the unique glioma immune microenvironment is a promising approach in developing breakthrough immunotherapy treatments. However, recent advances in immunotherapy, including the development of immune checkpoint inhibitors, have not improved t
Externí odkaz:
https://doaj.org/article/b12d5139e5f54e41bfca54e07b75f532
Autor:
Masahiro Ohgidani, Itaru Kushima, Shogo Inamine, Sota Kyuragi, Noriaki Sagata, Tomohiro Nakao, Shigenobu Kanba, Norio Ozaki, Takahiro A Kato
Publikováno v:
Psychiatry and clinical neurosciences.
Publikováno v:
Neuropsychopharmacology reportsREFERENCES.
Several studies reported stress-induced microglial phagocytosis, but the biochemical mechanisms by which stress alters microglial synaptic phagocytosis are not fully uncovered. Local or limited apoptosis without cell death was observed at neuronal sy
Autor:
Shogo Inamine, Shin Ichi Kano, Masutaka Furue, Masahiro Ohgidani, Makiko Nakahara-Kido, Yasunari Sakai, Noriaki Sagata, Takeshi Nakahara, Takahiro A. Kato, Shouichi Ohga, Shigenobu Kanba, Akira Sawa, Keiji Masuda, Hiroki Kato
Publikováno v:
Neuropsychopharmacology Reports
Aim Neurofibromatosis type 1 (NF1) is a multifaceted disease, and frequently comorbid with neurodevelopmental disorders such as autism spectrum disorder (ASD) and learning disorder. Dysfunction of adenylyl cyclase (AC) is one of the candidate pathway
Autor:
Kosuke Takigawa, Koji Iihara, Noritoshi Shirouzu, Masako Hosoi, Masahiro Ohgidani, Nobutaka Mukae, Takahiro A. Kato, Yuhei Sangatsuda, Satoshi O. Suzuki, Nobuhiro Hata, Masahiro Mizoguchi, Hideomi Hamasaki, Shogo Inamine, Yutaka Fujioka, Yusuke Funakoshi, Noriaki Sagata, Shunya Tanaka, Ryusuke Hatae, Toru Iwaki
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Targeting the unique glioma immune microenvironment is a promising approach in developing breakthrough immunotherapy treatments. However, recent advances in immunotherapy, including the development of immune checkpoint inhibitors, have not improved t
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 95:2-S22
Autor:
Mina Sato-Kasai, Shigenobu Kanba, Akira Monji, Yoshihiro Seki, Sota Kyuragi, Noriaki Sagata, Kohei Hayakawa, Yoshito Mizoguchi, Takahiro A. Kato, Shogo Inamine, Hideki Horikawa, Masahiro Ohgidani, Norihiro Shimokawa
Publikováno v:
Schizophrenia Research. 178:35-43
Viral infections during fetal and adolescent periods, as well as during the course of schizophrenia itself have been linked to the onset and/or relapse of a psychosis. We previously reported that the unique antipsychotic aripiprazole, a partial D2 ag